groups about duration of oxytocin drip, duration of
ruptured membrane, or body weight of the newborn
(Table 2). During labor and postpartum period, the
difference in the frequencies of oxytocin and Nalador usage were not statistically significant between the
two groups. However, the experimental group was given
ergometrine less frequently than those in the control
group (n = 71; 20.9% and n = 91; 26.9%, respectively).
Blood replacement was given in three cases, one case
in the experimental group and two cases in the control
group. The means of amount of blood loss in the third
stage of labor were statistically different (p = 0.005),
187.94 + 106.46 ml in the experimental group and 217.75
+ 160.37 ml in the control group. The means of amount
of blood loss in the fourth stage of labor were not
statistically different, 72.51 + 45.80 ml in the experimental
group and 71.95 + 50.90 ml in the control group.
Nevertheless, when considering the total amount of
blood loss, the difference is statistically significant (p
= 0.012). The total blood loss was less in the
experimental group (260.44 + 116.30ml) than that in the control group (289.70 + 179.53 ml) with a difference of
29.26 ml (Table 3).
The number of subjects who developed PPH
in the third stage of labor between the two groups was
significantly different (p = 0.006), four cases (1.2%) in
the experimental group and 16 cases (4.7%) in the
control group. However, when considering both the
third and the fourth stages, the number of PPH
increased by 6 in the experimental group and 7 in the
control group. Therefore, after two hours postpartum,
the total number of subjects with PPH in the control
group (23 cases; 6.8%) became 1.4 times that of the
experimental group (10 cases; 2.9%), which is
statistically significant (p = 0.02).